卵巢癌中的免疫检查点抑制剂:我们从这里走到哪里?
Won-Hee Yoon1,2,3,4, Anna DeFazio3,4,5,6, Lawrence Kasherman4,7
1Department of Medical Oncology, Blacktown Cancer and Haematology Centre, Blacktown Hospital, Blacktown 2148, Australia.
Cancer drug resistance (Alhambra, Calif.)
|July 17, 2023
概括
尽管治疗进展,上皮卵巢癌 (EOC) 仍然是致命的. 本综述考察了卵巢瘤微环境和新型免疫疗法来克服耐药性,为改善患者结果提供了希望.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 妇科恶性瘤 妇科恶性瘤
背景情况:
- 表皮卵巢癌 (EOC) 是妇科癌症死亡率的主要原因.
- 虽然免疫检查点抑制剂 (ICI) 等免疫疗法在其他癌症中表现出成功,但它们在EOC中的有效性有限.
- 了解卵巢瘤微环境 (TME) 是开发有效治疗方法的关键.
研究的目的:
- 审查卵巢瘤微环境 (TME) 及其对EOC患者存活率的影响.
- 探索当前和新兴的免疫治疗策略用于上皮卵巢癌.
- 在EOC治疗中研究克服药物耐药性的新疗法.
主要方法:
- 关于EOC,TME和免疫治疗的现有研究的综合文献综述.
- 分析TME中影响患者生存和治疗反应的因素.
- 探索新的免疫治疗方法和耐药性机制.
主要成果:
- 在EOC中,TME对有效的免疫疗法存在重大障碍.
- 特定的TME因素与差异性的患者生存结果有关.
- 新兴的免疫治疗策略显示出潜力,但需要对EOC进行进一步的研究.
结论:
- 尽管面临挑战,但新型免疫疗法在治疗上皮卵巢癌方面充满希望.
- 针对TME和克服耐药性是未来EOC研究的关键优先事项.
- 需要进行进一步的临床研究,以验证EOC的新免疫治疗策略.
更多相关视频
00:06An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
Published on: September 12, 2019
8.9K
09:40Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
2.7K
相关概念视频
01:27Tumor Immunotherapy
567
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
567
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K